600222 太龙药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.8352.766-4.4700.3852.070
总资产报酬率 ROA (%)0.7921.213-1.9540.1670.925
投入资产回报率 ROIC (%)1.1241.775-2.5040.1890.973

边际利润分析
销售毛利率 (%)26.48727.28224.07728.86026.454
营业利润率 (%)1.8402.134-3.6102.2192.328
息税前利润/营业总收入 (%)5.1164.662-0.9845.7016.837
净利润/营业总收入 (%)2.2342.166-3.8640.4221.947

收益指标分析
经营活动净收益/利润总额(%)-21.99079.25640.946909.53084.702
价值变动净收益/利润总额(%)29.369-14.95213.385-87.46324.101
营业外收支净额/利润总额(%)-1.029-2.80314.568-377.957-12.823

偿债能力分析
流动比率 (X)1.0741.2081.1771.1781.252
速动比率 (X)0.8150.9320.9160.9471.020
资产负债率 (%)56.50754.61455.24853.01954.842
带息债务/全部投入资本 (%)38.35030.32733.42139.474--
股东权益/带息债务 (%)151.497213.566190.278127.520106.550
股东权益/负债合计 (%)74.61480.80578.81482.77278.190
利息保障倍数 (X)1.5531.803-0.3041.0891.432

营运能力分析
应收账款周转天数 (天)157.430126.000112.925113.1660.000
存货周转天数 (天)133.549108.344100.644115.1150.000